Showing results (5511-5520 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|December 22, 2025
Metastatic Colorectal Adenocarcinoma with APC and EGFR L858R co-mutations: A Case ReportVitor Jodar Cavalheiro, Daniel Santos Rocha Sobral Filho, Giulia Mazaro de Oliveira, et al.
The Oncologist|December 22, 2025
Prospective patient navigation program for young women with breast cancer: assessment and referrals to address medical and supportive care needsFernanda Mesa-Chavez, Ana Rodriguez, Lucero Labra, et al.
The Oncologist|December 19, 2025
Real-World Effectiveness and Safety of Hyperthermic Intraperitoneal Chemotherapy and Intraperitoneal Chemotherapy in Ovarian CancerSiyi Zhang, Qian Qie, Yuan Zhang, et al.
The Oncologist|November 8, 2025
Digital integration of narrative medicine and patient-reported outcome measures to improve understanding of quality of life in metastatic breast cancer: the PERGIQUAL studyAlessandra Fabi, Maria Cecilia Cercato, Alessandro Rossi, et al.
The Oncologist|November 10, 2025
An early relapse prediction model based on pathological features following neoadjuvant immunotherapy for hepatocellular carcinomaYanrui Pang, Xuelian Zhao, Xinxin Guo, et al.
The Oncologist|October 30, 2025
UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinomaSyed Hussain, Aisling Carr, Simon John Crabb, et al.
The Oncologist|July 1, 2025
Mitigation and management of adverse events associated with amivantamab therapyNarjust Florez, Nicole R LeBoeuf, Julia Rotow, et al.
The Oncologist|June 26, 2025
The financial toll of cancer: uncovering the links between financial toxicity and symptom burdenMarco Filetti, Pasquale Lombardi, Gabriella Gentile, et al.
The Oncologist|July 16, 2025
Somatic Mutations in Middle East and North Africa (MENA) Breast Cancer Patients: A Systematic ReviewLama Abujamous, Isha Ahmed, Yasmin Ahen, et al.
The Oncologist|June 24, 2025
Retrospective multicenter analysis of real-life toxicity and outcome of ipilimumab and nivolumab in metastatic uveal melanomaAmélie Ciernik, Laure Ciernik, Peter Bonczkowitz, et al.
Pageof 571